Ralph W. Moss

710 total citations
28 papers, 521 citations indexed

About

Ralph W. Moss is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ralph W. Moss has authored 28 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ralph W. Moss's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers) and Complementary and Alternative Medicine Studies (3 papers). Ralph W. Moss is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers) and Complementary and Alternative Medicine Studies (3 papers). Ralph W. Moss collaborates with scholars based in United States, Hungary and Austria. Ralph W. Moss's co-authors include Tibor Bakács, Zhiyong Xu, Weimin Zhang, Yifan Luo, J.N. Mehrishi, László K. Csatáry, J. Beuth, József Szeberényi, Beáta Törőcsik and Attila Marcell Szász and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Pharmacological Research.

In The Last Decade

Ralph W. Moss

26 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph W. Moss United States 12 148 134 127 104 97 28 521
Takayoshi Tokiwa Japan 11 78 0.5× 40 0.3× 250 2.0× 42 0.4× 35 0.4× 33 583
Leila Bagheri Iran 8 113 0.8× 56 0.4× 76 0.6× 102 1.0× 28 0.3× 17 394
Alexandra Blatt Israel 7 76 0.5× 58 0.4× 244 1.9× 54 0.5× 73 0.8× 9 464
Angelika Bodenteich Austria 14 96 0.6× 48 0.4× 307 2.4× 41 0.4× 97 1.0× 24 764
Mingli Zhao China 14 73 0.5× 43 0.3× 228 1.8× 29 0.3× 124 1.3× 56 551
Crina Stăvaru Romania 12 70 0.5× 39 0.3× 159 1.3× 122 1.2× 34 0.4× 27 480
Haijun Liu China 10 60 0.4× 62 0.5× 346 2.7× 52 0.5× 18 0.2× 13 506
Ruizhe Zhang China 14 63 0.4× 41 0.3× 141 1.1× 129 1.2× 24 0.2× 49 533
Taylor L. Carlson United States 9 37 0.3× 58 0.4× 183 1.4× 22 0.2× 54 0.6× 14 498

Countries citing papers authored by Ralph W. Moss

Since Specialization
Citations

This map shows the geographic impact of Ralph W. Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph W. Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph W. Moss more than expected).

Fields of papers citing papers by Ralph W. Moss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph W. Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph W. Moss. The network helps show where Ralph W. Moss may publish in the future.

Co-authorship network of co-authors of Ralph W. Moss

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph W. Moss. A scholar is included among the top collaborators of Ralph W. Moss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph W. Moss. Ralph W. Moss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kerepesi, Csaba, Tibor Bakács, Ralph W. Moss, Shimon Slavin, & Colin C. Anderson. (2020). Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies. Cancer Immunology Immunotherapy. 69(5). 683–687. 16 indexed citations
2.
3.
4.
Bakács, Tibor, et al.. (2019). Exploiting autoimmunity unleashed by low‐dose immune checkpoint blockade to treat advanced cancer. Scandinavian Journal of Immunology. 90(6). e12821–e12821. 21 indexed citations
5.
6.
7.
Slavin, Shimon, Ralph W. Moss, & Tibor Bakács. (2013). Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunity. Pharmacological Research. 79. 9–12. 8 indexed citations
8.
Bakács, Tibor, et al.. (2012). Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy). Pharmacological Research. 66(2). 192–197. 11 indexed citations
9.
Bakács, Tibor, J.N. Mehrishi, & Ralph W. Moss. (2011). Ipilimumab (Yervoy) and the TGN1412 catastrophe. Immunobiology. 217(6). 583–589. 32 indexed citations
10.
Luo, Yifan, et al.. (2010). Rationale of Combined PDT and SDT Modalities for Treating Cancer Patients in Terminal Stage—The Proper Use of Photosensitizer: A Reply. Integrative Cancer Therapies. 9(4). 320–321. 4 indexed citations
11.
Zhang, Weimin, et al.. (2009). Sonodynamic and Photodynamic Therapy in Advanced Breast Carcinoma: A Report of 3 Cases. Integrative Cancer Therapies. 8(3). 283–287. 111 indexed citations
12.
Moss, Ralph W.. (2008). An Annotated Bibliography of Works by John Beard. Integrative Cancer Therapies. 7(4). 317–321. 4 indexed citations
13.
Moss, Ralph W.. (2008). The Life and Times of John Beard, DSc (1858-1924). Integrative Cancer Therapies. 7(4). 229–251. 6 indexed citations
14.
Moss, Ralph W.. (2007). Do Antioxidants Interfere With Radiation Therapy for Cancer?. Integrative Cancer Therapies. 6(3). 281–292. 61 indexed citations
15.
Moss, Ralph W.. (2007). Women in the front line. The New Scientist. 194(2605). 55–55. 2 indexed citations
16.
Moss, Ralph W.. (2006). Should Patients Undergoing Chemotherapy and Radiotherapy Be Prescribed Antioxidants?. Integrative Cancer Therapies. 5(1). 63–82. 48 indexed citations
17.
18.
Moss, Ralph W.. (2001). The Grand Illusion of Chemotherapy1. 33(1). 15–18. 3 indexed citations
19.
Csatáry, László K., Ralph W. Moss, J. Beuth, et al.. (1999). Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).. PubMed. 19(1B). 635–8. 71 indexed citations
20.
Moss, Ralph W.. (1970). The Language Criticism and the Sciences of Man: The Structuralist Controversy. Telos. 1970(6). 354–359. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takayoshi Tokiwa Breakdown of academic impact, for papers by Leila Bagheri Breakdown of academic impact, for papers by Alexandra Blatt Breakdown of academic impact, for papers by Angelika Bodenteich Breakdown of academic impact, for papers by Mingli Zhao Breakdown of academic impact, for papers by Crina Stăvaru Breakdown of academic impact, for papers by Haijun Liu Breakdown of academic impact, for papers by Ruizhe Zhang Breakdown of academic impact, for papers by Taylor L. Carlson
Rankless by CCL
2026